Summarized by Masters of Longevity from Longevity Docs News.
Kyoto University transplanted Amchepry into a Parkinson's patient in October.
Key Takeaways
- Kyoto University Hospital performed the first post-approval transplant.
- Japan's approval was conditional after a small uncontrolled seven‑patient trial.
- Long-term safety, efficacy and immunosuppression needs remain unproven.
